You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis

 

Online download statistics by month:

Online download statistics by month: March 2021 to March 2026

AbstractFullPdf
Mar 2021470469202
Apr 2021179179100
May 202122022097
Jun 202123323356
Jul 202111911939
Aug 202112112137
Sep 202111211254
Oct 202112912954
Nov 202111811761
Dec 20219810539
Jan 2022636527
Feb 2022536034
Mar 202210211352
Apr 202214014958
May 2022838647
Jun 2022636725
Jul 2022667336
Aug 2022717533
Sep 2022899660
Oct 2022808152
Nov 2022687057
Dec 2022696936
Jan 2023757648
Feb 2023969749
Mar 2023656544
Apr 2023515128
May 2023515137
Jun 2023565645
Jul 2023858651
Aug 202313613549
Sep 202311812231
Oct 202322922936
Nov 202338738736
Dec 2023515135
Jan 2024495136
Feb 2024525238
Mar 2024414241
Apr 2024586043
May 2024495029
Jun 2024545663
Jul 2024454625
Aug 2024464324
Sep 2024353521
Oct 2024414124
Nov 2024535425
Dec 2024848638
Jan 2025787844
Feb 202515915941
Mar 2025717260
Apr 2025949451
May 2025494933
Jun 2025515133
Mar 2026220
Total525753352414